Skip to main content

Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis

Fig. 2

Anti-CXCR3 (left) and anti-CXCR4 (right) antibody levels in diffuse cutaneous systemic sclerosis (dSSc), in patients with limited cutaneous systemic sclerosis (lSSc), with overlap syndromes (Overlap), with undifferentiated connective tissue disease (UCTD), and in healthy controls. P values with significant differences are shown

Back to article page